Recent VERV News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 11:30:33 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:15:11 AM
- Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/08/2024 11:00:00 AM
- Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102 • GlobeNewswire Inc. • 05/07/2024 11:00:00 AM
- Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 08:01:00 PM
- Verve Therapeutics Announces Updates on its PCSK9 Program • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
- Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/28/2024 08:51:34 PM
- Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/01/2024 09:01:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2024 01:32:23 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 01:00:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 12:45:10 PM
- Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/27/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:30:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:30:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:30:11 PM
- Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference • GlobeNewswire Inc. • 02/01/2024 11:30:00 AM
- Verve Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/02/2024 11:30:11 AM
- Verve Therapeutics Announces Closing of Public Offering of Common Stock, Full Exercise by Underwriters of Option to Purchase Additional Shares and Closing of Concurrent Private Placement • GlobeNewswire Inc. • 12/01/2023 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:54:53 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/29/2023 09:47:16 PM
- Verve Therapeutics Shares Tumble Premarket After Stock Sales • Dow Jones News • 11/29/2023 11:47:00 AM
- Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement • GlobeNewswire Inc. • 11/29/2023 03:37:08 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/28/2023 09:25:14 PM
- Verve Therapeutics Announces Proposed Public Offering of Common Stock and Concurrent Private Placement • GlobeNewswire Inc. • 11/28/2023 09:01:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 11:34:58 AM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM